The company initiated its next development program for etripamil, starting a Phase III AFib-RVR trial. “We have initiated our Phase III trial for atrial fibrillation with rapid ventricular rate or ...

If you've been relying on Express Scripts for your 90-day refills and home delivery, 2026 brings a critical shift: a new 'Copay Assurance' program that caps out-of-pocket costs, paired with stricter ...

A Baton Rouge judge allowed Louisiana Insurance Commissioner Tim Temple’s pharmacy reimbursement directive to take effect, ...

Milestone Pharmaceuticals Inc (MIST) reports a successful product launch and strategic trials, despite facing early-stage revenue hurdles and increased expenses.

Louisiana Department of Insurance, orders PBMs and insurers in the state to bring their reimbursement formulas in line with a ...

Managing pharmacy needs in 2026 requires a sharper eye on timing than ever before, especially with Express Scripts enforcing stricter refill windows and delivery schedules that can leave you without ...

Future commercial investments will be ROI-driven, with potential sales force expansion and increased patient activation ...

More than 90% of employers agreed a rebate-free approach is easier to understand and would improve drug price transparency, ...

Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or ...

Employers want greater transparency in their pharmacy benefits, with many viewing a model that eschews rebates as a key way ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Milestone Pharmaceuticals (NASDAQ:MIST) held its first-quarter earnings conference call on Wednesday. Below is the complete ...